Congo completes surveillance of Ebola contacts, no new cases

GOMA, Democratic Republic of Congo (Reuters) - Democratic Republic of Congo moved closer to declaring its Ebola outbreak over when the health ministry said it had completed surveillance of the last people who came into contact with patients and had not found any new cases. If no further cases of the deadly disease are confirmed after one more three-week incubation period, Congo will be able to officially declare an end to the outbreak, which is believed to have killed 29 people since April. Health officials have traced contacts and deployed an experimental vaccine in northwestern Congo to head off what they feared could have become a wider contagion after the virus spread to Mbandaka, a river port city of more than 1 million people.

Reuters June 29, 2018 01:06:29 IST
Congo completes surveillance of Ebola contacts, no new cases

Congo completes surveillance of Ebola contacts no new cases

GOMA, Democratic Republic of Congo (Reuters) - Democratic Republic of Congo moved closer to declaring its Ebola outbreak over when the health ministry said it had completed surveillance of the last people who came into contact with patients and had not found any new cases.

If no further cases of the deadly disease are confirmed after one more three-week incubation period, Congo will be able to officially declare an end to the outbreak, which is believed to have killed 29 people since April.

Health officials have traced contacts and deployed an experimental vaccine in northwestern Congo to head off what they feared could have become a wider contagion after the virus spread to Mbandaka, a river port city of more than 1 million people.

The latest outbreak has been seen as a test of global health authorities' ability to counter Ebola after being criticised for responding too slowly to an epidemic in West Africa from 2013-2016 that killed more than 11,000 people.

More than 3,300 people have received Merck's experimental vaccine and health workers kept a watch on 1,706 people who came into contact with Ebola patients, officials said.

"The use of vaccination in this Ebola response has been a game-changer as it allowed us to break the chain of transmission and contain the virus more quickly," the health ministry said in a statement on Thursday.

"So far, the results of the vaccination have been promising as none of the individuals who were vaccinated developed the disease nor experienced major side effects," it added.

This is Congo's ninth outbreak of Ebola since the virus was discovered near northern Congo's eponymous river in 1976.

Ebola is known and feared for the internal and external bleeding it can cause in its victims, owing to damage done to blood vessels. Victims often die of shock.

(Reporting By Fiston Mahamba and Aaron Ross; Editing by Andrew Heavens)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Cargo from Dubai arrives in Haifa, cementing Israel-UAE trade route
Business

Cargo from Dubai arrives in Haifa, cementing Israel-UAE trade route

By Rami Amichay HAIFA, Israel (Reuters) - The ship-to-shore crane paused above the cargo ship just arrived from Dubai, then set its load down on the pier in Israel.

As globe gallops into vaccine trials, insurers remain unfazed
Business

As globe gallops into vaccine trials, insurers remain unfazed

By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger LONDON/FRANKFURT (Reuters) - The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour. Yet, while more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don't see anything to be unduly concerned about.

EU watchdog to clarify share trading after full Brexit
Business

EU watchdog to clarify share trading after full Brexit

By Huw Jones LONDON (Reuters) - The European Union's securities watchdog said it expects to make a statement soon on where shares listed in the bloc must be traded after Britain's full departure from the European Union in December.